References
- Dauer WT, Burke RE, Greene P, et al. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998;121:547-60
- Jahanshahi M, Marsden CD. A longitudinal follow-up study of depression, disability, and body concept in torticollis. Behav Neurol 1990;3:233-46
- Claypool DW, Duane DD, Ilstrup DM, et al. Epidemiology and outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota. Mov Disord 1995;10:608-14
- Jahanshahi M. Psychosocial factors and depression in torticollis. J Psychosom Res 1991;35:493-507
- Jahanshahi M, Marsden CD. Body concept, disability, and depression in patients with spasmodic torticollis. Behav Neurol 1990;3:117-31
- Hsiung GY, Das SK, Ranawaya R, et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002;17:1288-93
- Swope D, Barbano R. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurol Clin 2008;26(1 Suppl):54-65
- Costa J, Espirito-Santo C, Borges A, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005:CD003633
- Benecke R, Jost WH, Kanovsky P, et al. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 2005;64:1949-51
- Ferreira JJ, Costa J, Coelho M, et al. The management of cervical dystonia. Expert Opin Pharmacother 2007;8:129-40
- Brashear A. Botulinum toxin type A in the treatment of patients with cervical dystonia. Biologics 2009;3:1-7
- Cano SJ, Hobart JC, Edwards M, et al. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. Neurology 2006;67:2230-2
- Cano SJ, Warner TT, Linacre JM, et al. Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58). Neurology 2004;63:1629-33
- Gudex CM, Hawthorne MR, Butler AG, et al. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord 1998;13:941-6
- Brashear A. The botulinum toxins in the treatment of cervical dystonia. Semin Neurol 2001;21:85-90
- Skogseid IM, Roislien J, Claussen B, et al. Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia. Mov Disord 2005;20:1604-9
- Molho ES, Agarwal N, Regan K, et al. Effect of cervical dystonia on employment: a retrospective analysis of the ability of treatment to restore premorbid employment status. Mov Disord 2009;24:1384-7
- Skogseid IM, Kerty E. The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 2005;12:163-70
- Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994;9:213-7